Cidara Therapeutics (CDTX)
(Delayed Data from NSDQ)
$11.21 USD
-0.79 (-6.58%)
Updated May 17, 2024 04:00 PM ET
After-Market: $11.65 +0.44 (3.93%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/01/2024
Time: -- |
6/2024 | $-3.94 | 0.00% |
Earnings Summary
For their last quarter, Cidara Therapeutics (CDTX) reported earnings of -$2.28 per share, missing the Zacks Consensus Estimate of -$1.50 per share. This reflects a negative earnings surprise of 52.00%. Look out for CDTX's next earnings release expected on August 01, 2024. For the next earning release, we expect the company to report earnings of -$3.94 per share, reflecting a year-over-year decrease of 40.71%.
Earnings History
Price & Consensus
Zacks News for CDTX
TELA Bio, Inc. (TELA) Reports Q4 Loss, Tops Revenue Estimates
CDTX: What are Zacks experts saying now?
Zacks Private Portfolio Services